Hyperparathyroidism: all 309 studies
Page 3 of 4. Open to participants first (23), then studies with results posted, then the rest; newest registration first within each.
- Interest of the F18-choline as a Second Line of the Tracer for Detection of Parathyroid AdenomasCompletedNCT02432599Phase 2
- Efficacy of Cinacalcet in the Control of Primary HyperparathyroidismCompletedNCT02417389Phase 4
- Multicenter Registry Comparing Preoperative Imaging for Primary HyperparathyroidismWithdrawnNCT02381925
- Cinacalcet in Management of Secondary Hyperparathyroidism in Haemodialysis PatientsStatus unknownNCT02338934Phase 4
- The Efficacy and Safety of Microwave Ablation for Mild-to-moderate Secondary Hyperparathyroidism Patients Undergoing HemodialysisStatus unknownNCT02332135Not applicable
- Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic AcidCompletedNCT02274623Phase 1
- Optimal Anemia Treatment in End Stage Renal Disease (ERSD)Status unknownNCT02273570Not applicable
- Primary Hyperparathyroidism: Short-term Calcimimetics Treatment - Relevance for Parathyroid Surgery Decisions?CompletedNCT02227264Not applicable
- Phase 2 Study of KHK7580CompletedNCT02216656Phase 2
- Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Peritoneal DialysisCompletedNCT02143271Phase 1
- A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing HemodialysisCompletedNCT02133404Phase 2
- Intra-operative Infra-red Fluorescent Imaging in Thyroid and Parathyroid SurgeryCompletedNCT02089542Phase 1/2
- The Study of Efficacy and Safety of REGPARA Drug in Dialysis Patients Have High Blood Levels of ParathyroidCompletedNCT02056730Phase 4
- EC17 for Intraoperative Imaging for ParathyroidectomyCompletedNCT01996072Phase 1
- Phase 1/2 Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving HemodialysisCompletedNCT01935856Phase 1/2
- A Phase 2 Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism in Patients on HemodialysisCompletedNCT01922843Phase 2
- OPG/Soluble RANKL (sRANKL) and Bone Mineral Density in Primary HyperparathyroidismCompletedNCT01889134Not applicable
- Short- and Long-Term Impact of Subtotal Parathyroidectomy on the Achievement of Bone and Mineral Parameters Recommended by Clinical Practice Guidelines in Dialysis PatientsCompletedNCT01872429
- 11C Methionine PET for the Detection of Hyperfunctional Parathyroid TissuesStatus unknownNCT01783002Phase 2
- Evaluation of Non Specific Symptoms and Quality of Life Before and After Surgery for Mild Primary HyperparathyroidismCompletedNCT01776502
- Morbidity Related to Secondary Hyperparathyroidism After Renal TransplantationCompletedNCT01741064
- Vitamin D Supplementation in HIV-infected YouthCompletedNCT01656070Phase 2
- A Phase 2A Dose-ranging and Pharmacokinetic Study of an Oral Vitamin D Compound (DP001) in Secondary HyperparathyroidismCompletedNCT01653379Phase 2
- Differentially Expressed Proteins in Sporadic Parathyroid TumorsStatus unknownNCT01647503
- Near Infrared Fluorescent Imaging in Thyroid and Parathyroid Surgery With the Fluobeam(TM) System of FluopticsCompletedNCT01598727Phase 1
- Treatment Adhesion in Dialysis Patients Treated With CinacalcetCompletedNCT01573520Phase 4
- Radius Loading in Primary HyperparathyroidismCompletedNCT01571843Not applicable
- Minimally Invasive Radioguided ParathyroidectomyCompletedNCT01530919
- Surgical Approach for Primary Hyperparathyroidism in the ElderlyWithdrawnNCT01484379Not applicable
- Cinacalcet in Paediatric Secondary Hyperparathyroidism (SHPT) Due to Chronic Kidney Disease (CKD)Status unknownNCT01479088Phase 2/3
- An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary HyperparathyroidismCompletedNCT01460030Phase 3
- Four Week, Pharmacodynamic/Pharmacokinetic, Efficacy, and Safety Study of Lunacalcipol (CTA018)WithdrawnNCT01453634Phase 2
- Cinacalcet Versus Parathyroidectomy in Peritoneal Dialysis PatientsCompletedNCT01447368Phase 4
- Effects of Vitamin D on Renal Blood Flow, Proteinuria and Inflammation in Patients With Chronic Kidney DiseaseWithdrawnNCT01426724Not applicable
- Efficacy and Safety of High Intensity Focused Ultrasound (HIFU) Device to Treat Secondary HyperparathyroidismWithdrawnNCT01421407Not applicable
- The Midwest Head and Neck Cancer Consortium Multi-Institutional Parathyroid RegistryCompletedNCT01409798
- Informed Consent for Whole Genome Sequencing: Ideals and Norms Referenced by Early ParticipantsCompletedNCT01369953
- One Week Comparison Study of PTH and PTHrP InfusionsWithdrawnNCT01333267Phase 1
- Primary Hyperparathyroidism (PHPT): Early Effect of Vitamin DWithdrawnNCT01329666Phase 2/3
- Coexisting Thyroid Disease and HyperparathyroidismCompletedNCT01306916
- Regulation of Vitamin D Receptor (VDR),Calcium Sensing Receptor (CaSR), Cyclin D1,Ki67 and Proliferating Cell Nuclear Antigen (PCNA) in Primary HyperparathyroidismStatus unknownNCT01228786
- The Novel Approach of Minimally Invasive Parathyroid Surgery Requires Precise Identification and Localization of the Lesion Prior to ExplorationStatus unknownNCT01226810
- Systematic Treatment After Successful Surgical Treatment for Primary Hyperparathyroidism With Strontium RanelateCompletedNCT01222026Phase 4
- Input of C11-Choline PET/CT in Localization of Parathyroid AdenomaStatus unknownNCT01221896
- Paricalcitol in Reducing Parathyroid Hormone Levels and Ameliorating Markers of Bone Remodelling in Renal Transplant Recipients With Secondary HyperparathyroidismCompletedNCT01220050Phase 2
- Parathyroidectomy vs Cinacalcet in the Treatment of Secondary Hyperparathyroidism Post Renal TransplantationCompletedNCT01178450Phase 4
- A Prospective Cohort Study to Describe the Evolution of Persistent Hyperparathyroidism in Kidney Transplant RecipientsCompletedNCT01163669
- A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary HyperparathyroidismCompletedNCT01149291
- Cincalcet and Vascular Arterial Stiffness Among Peritoneal Dialysis Patients With Secondary HyperparathyroidismCompletedNCT01143987Phase 4
- Efficacy and Safety of Alfacalcidol Compared to Calcitriol for Treatment of Secondary HyperparathyroidismCompletedNCT01115543Phase 4
- Cinacalcet stUdy for Peritoneal Dialysis Patients In Double Arm on the Lowing Effect OF iPTH LevelCompletedNCT01101113Phase 4
- Effects of Parathyroidectomy on Cardiovascular Risk Factors in Primary HyperparathyroidismCompletedNCT01057732
- Oral Peptones Load in Normocalcemic and Hypercalcemic Primary Hyperparathyroidism and Healthy SubjectsCompletedNCT01042626Not applicable
- Vitamin D Status in Males in Jerusalem Area and Its Correlation to Parathyroid Hormone (PTH) Level and Bone Mineral DensityCompletedNCT01025128Phase 4
- Mineral and Bone Disorders Outcomes in Stage 5D of Chronic Kidney DiseaseCompletedNCT00995163
- Vitamin D Supplementation After Parathyroid SurgeryCompletedNCT00982722Not applicable
- Primary Hyperparathyroidism: Does a Systematic Treatment Improve the Calcium and Bone Metabolism After Surgery?Status unknownNCT00973336Phase 2
- Lipids Profile in Primary HyperparathyroidismTerminatedNCT00961701
- Vitamin D Deficiency in Chronic Kidney Disease (CKD) PatientsCompletedNCT00958451Phase 4
- A Multicenter, Open-label Extension Study to Assess the Long-term Safety and Efficacy of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary HyperparathyroidismCompletedNCT00936988Phase 2
- A Study to Assess the Efficacy and Safety of Twice-Daily Dose Regimens of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism (PHPT)CompletedNCT00936650Phase 2
- Quality of Life in Patients Undergoing ParathyroidectomyCompletedNCT00905866
- Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease SubjectsCompletedNCT00888069Phase 1
- Pilot Study: Hypovitaminosis D, Hyperparathyroidism and Hypomagnesemia in Patients With Congestive Heart FailureCompletedNCT00887666
- Open Versus Video-Assisted Minimal-Invasive Parathyroid SurgeryCompletedNCT00877981Not applicable
- Safety and Efficacy Study of Paricalcitol Versus Calcitriol in the Treatment of Secondary HyperparathyroidismCompletedNCT00800358Not applicable
- Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT)CompletedNCT00792857Phase 1
- Prevention of Secondary Hyperparathyroidism With Vitamin D in Stage II/III Chronic Kidney DiseaseCompletedNCT00781417Not applicable
- Study of 1.25 mmol/L Calcium Dialysate on Mineral Metabolism in Haemodialysis Patients.CompletedNCT00744302Phase 2
- Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney DiseaseCompletedNCT00742716Phase 2
- Bioequivalency Study of Calcitriol Tablets Under Fasting ConditionsCompletedNCT00601328Not applicable
- Energy Specific Far Infrared Radiation Treatment for HyperparathyroidismStatus unknownNCT00573573Phase 1
- Regulation of Bone Formation in Renal OsteodystrophyCompletedNCT00560300Phase 2
- Effects of Vitamin D Replacement in Patients With Primary Hyperparathyroidism (PHPT)CompletedNCT00538720Phase 1
- Safety and Efficacy Study of AMG 073 in Hemodialysis SubjectsCompletedNCT00527267Phase 3
- Asymptomatic Primary Hyperparathyroidism: A Prospective, Randomized TrialCompletedNCT00522028
- Interaction Between Anaesthetics and Methylene BlueCompletedNCT00513032
- Effect of Parathyroidectomy on SleepCompletedNCT00501215Not applicable
- Treatment of Secondary Hyperparathyroidism in the Uremic PatientTerminatedNCT00469599Not applicable
- A Phase 4 Study to Determine Dosing of Hectorol® Capsules When Converting From Zemplar® InjectionCompletedNCT00463021Phase 4
- A Phase 4 Pharmacokinetic Study of Hectorol Injection and Zemplar Injection in CKD Subjects on HemodialysisCompletedNCT00454350Phase 4
- The Effect of Parathyroidectomy on Renal Function, Endothelial Function, and Blood PressureStatus unknownNCT00452049
- Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving HemodialysisTerminatedNCT00446329Phase 4
- Primary Hyperparathyroidism: Non-classical ManifestationsCompletedNCT00432939
- A Phase 4, Conversion Study of Hectorol® Injection to Hectorol® Capsules in Stage 5 CKD Patients on DialysisCompletedNCT00418600Phase 4
- Evaluation of Colecalciferol Substitution in Dialysis PatientsCompletedNCT00397475Not applicable
- Post Transplant StudyCompletedNCT00395902
- The Effects of Alendronate After Cure of Primary HyperparathyroidismWithdrawnNCT00359385Phase 4
- Cinacalcet to Treat Familial Primary HyperparathyroidismCompletedNCT00325104Phase 3
- Initial Dosing of Paricalcitol in Secondary HyperparathyroidismCompletedNCT00307840Phase 4
- Characterization of Hyperparathyroidism and Vitamin D Deficiency in ObesityCompletedNCT00288873Phase 4
- CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis PatientsCompletedNCT00211939Phase 4
- A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD)CompletedNCT00189501
- Active Vitamin D Effect on Left Ventricular HypertrophyTerminatedNCT00175149Phase 4
- Randall's Plaque Study: Pathogenesis and Relationship to NephrolithiasisActive, not recruitingNCT00169806Not applicable
- ACHIEVE: Optimizing the Treatment of Secondary HyperparathyroidismCompletedNCT00135304Phase 4
- START: Sensipar Treatment Algorithm to Reach K/DOQI Targets in Chronic Kidney Disease Subjects With Secondary HyperparathyroidismCompletedNCT00132431Phase 4
- Study of Safety and Efficacy of Doxercalciferol in Patients With Chronic Kidney Disease, Stage 3 or 4, and Secondary HyperparathyroidismCompletedNCT00123461Phase 4
- SENSOR: Study to Investigate Cinacalcet Treatment in Haemodialysis Patients With Secondary HyperparathyroidismCompletedNCT00117052Phase 3
- Treatment for Patients With Secondary Hyperparathyroidism of End-Stage Renal Disease (ESRD)CompletedNCT00110929Phase 2